There is some debate over whether this qualifies as a blue-collar job. After all, ATCs usually earn more than $100,000 per year, work in an office-type surrounding, and supervise airline pilots, who themselves earn six-figure salaries.
Good news everyone! The Patent Office has granted a patent on a cure for cancer. Last December, the Patent Office issued Patent No. 8,609,158 on a âpotent drugâ that ârebukes cancer, cancer cells, and kills cancer.â According to the patent, this drug cures a litany of other maladies.
Published Online: Monday, Nov 02, 2015. Roger M. Perlmutter, MD, PhD. The FDA has granted a breakthrough therapy designation to pembrolizumab (Keytruda) as a potential therapy for patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC), according to a statement from the company developing the PD-1 inhibitor, Merck.